- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 82
Sense picks up $50m
First reported late last year, Sense Biodetection has confirmed a $50m series B round backed by Cambridge Innovation Capital.
Apr 21, 2021Dott to deploy $85m of series B funding
Prosus Ventures participated in a debt and equity round for the e-scooter rental service provider, whose earlier investors include Axel Springer.
Apr 21, 2021Sense picks up $50m
Koch Disruptive Technologies led the molecular diagnostics test developer’s series B round, which will support the progression of its covid-19 test to market.
Apr 21, 2021Bushel bags $47m in series C round
Continental Grain co-led the agriculture software developer's latest round, which includes Cargill and Scoular, with Consolidated Grain and Barge to potentially join.
Apr 21, 2021Alphabet assists Mantl in $40m series B
Alphabet’s CapitalG unit led a round that increased the banking technology developer's overall funding to more than $60m.
Apr 21, 2021Lumicks leverages series D investors
Lumicks, which is developing single-molecule analysis technology based on research at Vrije Universiteit Amsterdam, has collected $93m.
Apr 20, 2021Lumicks leverages SoftBank to raise $93m
SoftBank’s Vision Fund 2 has taken part in a series D round for Lumicks, which is developing single-molecule analysis technology.
Apr 20, 2021Tectonic shifts $80m into series A
Tectonic Therapeutic is the latest venture undertaken by Harvard’s serial entrepreneur Timothy Springer, who co-led the series A round.
Apr 20, 2021Daily Deal Round Up: April 19, 2021
EV Growth-backed online education platform developer Ruangguru pulled in $55m while ProSieben and Rocket Internet helped open banking platform developer Tink take its total funding to $344m.
Apr 19, 2021Alchemab accesses $82m series A
Alchemab Therapeutics has raised $80m to advance research originating at University of Oxford, Johns Hopkins University and Mount Sinai Hospital.
Apr 19, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


